Clinical Trial: Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225244) titled 'Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction' on Nov. 03.

Brief Summary: Primary acquired nasolacrimal duct obstruction

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Primary Acquired Nasolacrimal Duct Obstruction

Intervention: DEVICE: 2 point balloon dacryoplasty with LacriCATH(R)

Balloon dacryoplasty with LacriCATH(R) (QUEST Medical Inc., Allen, TX, USA, 3 mm balloon diameter, 15 mm in length). The balloon will be inflated to 8 bars of pressure for 90 seconds, deflated, and re-inflated to 8 bars of pressure for an addit...